The present disclosure provides humanized anti C1s antibodies. The present disclosure provides nucleic acids comprising nucleotide sequences encoding the humanized anti C1s antibodies; and host cells comprising the nucleic acids. The present disclosure provides compositions comprising the humanized anti C1s antibodies. The present disclosure provides methods of use of the humanized anti C1s antibodies.